| Literature DB >> 30061177 |
Lan Yi1,2, Hongxiang Mu2, Nan Hu1, Jing Sun2, Jie Yin1,2, Keren Dai2, Dingxin Long1, Dexin Ding3.
Abstract
Uranium tailings (UT) are formed as a byproduct of uranium mining and are of potential risk to living organisms. In the present study, we sought to identify potential biomarkers associated with chronic exposure to low dose rate γ radiation originating from UT. We exposed C57BL/6J mice to 30, 100, or 250 μGy/h of gamma radiation originating from UT samples. Nine animals were included in each treatment group. We observed that the liver central vein was significantly enlarged in mice exposed to dose rates of 100 and 250 μGy/h, when compared with nonirradiated controls. Using proteomic techniques, we identified 18 proteins that were differentially expressed (by a factor of at least 2.5-fold) in exposed animals, when compared with controls. We chose glycine N-methyltransferase (GNMT), glutathione S-transferase A3 (GSTA3), and nucleophosmin (NPM) for further investigations. Our data showed that GNMT (at 100 and 250 μGy/h) and NPM (at 250 μGy/h) were up-regulated, and GSTA3 was down-regulated in all of the irradiated groups, indicating that their expression is modulated by chronic gamma radiation exposure. GNMT, GSTA3, and NPM may therefore prove useful as biomarkers of gamma radiation exposure associated with UT. The mechanisms underlying those changes need to be further studied.Entities:
Keywords: C57BL/6J mice; chronic gamma radiation; liver; protein expression; uranium tailings
Mesh:
Substances:
Year: 2018 PMID: 30061177 PMCID: PMC6200700 DOI: 10.1042/BSR20180536
Source DB: PubMed Journal: Biosci Rep ISSN: 0144-8463 Impact factor: 3.840
The primer sequences for GNMT, GSTA3, NPM, and Actb
| Gene | Primer sequence | Length |
|---|---|---|
| F: 5′AACTGGTTGACGCTGGACAA-3′ | 133 bp | |
| R: 5′TGTTCTTTAGTGCCAGCCGG-3′ | ||
| F: TCGACGGGATGAAACTGGTG | 128 bp | |
| R: CAGATCCGCCACTCCTTCTG | ||
| F: GAAGTGTGGTTCAGGGCCTG | 122 bp | |
| R: ATCGCTTTCCAGACATGCCT | ||
| F: 5′ GCCAACCGTGAAAAGATGAC 3′ | 541 bp | |
| R: 5′ GAGGCATACAGGGACAGCAC 3′ |
Figure 1Morphology of liver tissues obtained from mice that were chronically exposed to 30, 100, and 250 μGy/h
Figure 22-DE of total liver protein obtained from mice that were chronically exposed to 30, 100, and 250 μGy/h
Figure 3PMF print of protein spot C04 obtained using MALDI-TOF-MS
Differentially expressed proteins identified by MALDI-TOF-MS
| Spot | Entry name | Protein identified | Score | Mr (Da) | IP | Squence coverge | Function |
|---|---|---|---|---|---|---|---|
| 09 | IDI1_MOUSE | Isopentenyl-diphosphate Delta-isomerase 1* | 166 | 26615 | 5.79 | 37% | Catalysis |
| B07 | CPSM_MOUSE | Carbamoyl-phosphate synthase [ammonia], mitochondrial† | 235 | 165711 | 6.48 | 8% | Catalysis |
| C01 | K2C8_MOUSE | Keratin, type II cytoskeletal 8* | 172 | 54531 | 5.7 | 22% | Cytoskeletal protein/protection |
| C04 | GNMT_MOUSE | Glycine N-methyltransferase * | 236 | 33111 | 7.1 | 45% | Metabolic enzyme regulates lipid and glucose homeostasis |
| C07 | D3YU12_MOUSE | NmrA-like family domain-containing protein 1* | 150 | 33232 | 6.32 | 25% | Domain protein |
| C11 | CMBL_MOUSE | Carboxymethylenebutenolidase homolog* | 140 | 28226 | 6.71 | 32% | Hydrolases |
| C12 | QOR_MOUSE | Quinone oxidoreductase* | 177 | 35531 | 8.18 | 18% | Chemical carcinogen metabolizing enzyme |
| D18 | GSTP1_MOUSE | Glutathione S-transferase P 1† | 265 | 23765 | 7.68 | 42% | Liver detoxification |
| D19 | GSTA3_MOUSE | Glutathione S-transferase A3† | 171 | 25401 | 8.76 | 55% | Carcinogenesis |
| D20 | A0A087WQI6_MOUSE | Glutathione S-transferase (Fragment)† | 60 | 15359 | 5.38 | 8% | Liver detoxification |
| D21 | BHMT1_MOUSE | Betaine–homocysteine S-methyltransferase 1† | 172 | 45448 | 8.01 | 20% | Zinc-dependent enzyme/catalysis |
| E08 | NPM_MOUSE | Nucleophosmin* | 72 | 32711 | 4.62 | 23% | Cell growth, proliferation, and apoptosis/carcinogenesis |
| E09 | ALBU_MOUSE | Serum albumin* | 198 | 70700 | 5.75 | 21% | Maintaining the oncotic pressure/free radical scavenging |
| E11 | TBB5_MOUSE | Tubulin β-5 chain* | 136 | 50095 | 4.78 | 14% | Cytoskeletal protein |
| E14 | HUTH_MOUSE | Histidine ammonia-lyase* | 207 | 72897 | 5.94 | 20% | Catalysis |
| E15 | GNMT_MOUSE | Glycine N-methyltransferase* | 230 | 33111 | 7.1 | 34% | Metabolic enzyme regulates lipid and glucose homeostasis |
| E16 | HGD_MOUSE | Homogentisate 1,2-dioxygenase* | 123 | 50726 | 6.86 | 17% | Catalysis |
| E20 | Q9CPX4_MOUSE | Ferritin light chain 1* | 378 | 20817 | 5.66 | 65% | Iron metabolism |
*Up-regulated compared with the control group.
†Down-regulated compared with the matched group.
Figure 4qPCR verification of GNMT, GSTA3, and NPM gene expression in liver obtained from mice that were chronically exposed to 30, 100, and 250 μGy/h.
Figure 5WB verification of GNMT, GSTA3, and NPM expression in liver obtained from mice that were chronically exposed to 30, 100, and 250 μGy/h.
(A) Representative WB of GNMT, GSTA3, and NPM expression in the liver tissues of mice treated with or without the indicated doses of irradiation (β-actin served as the internal control). (B) Quantification of GNMT, GSTA3, and NPM expression, evaluated by WB analysis. Values are presented as the mean ± S.D. from three experiments. We used ttest to test the differences between groups and *P<0.05 was considered significant.